Thrombomodulin inhibits the activation of factor XIII by thrombin

Driving safety improves after individualized training: An RCT involving older drivers in an urban area.

Traffic injury prevention·2019

Auto- and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.

Journal of thrombosis and haemostasis : JTH·2018

Minimal factor XIII activity level to prevent major spontaneous bleeds.

Journal of thrombosis and haemostasis : JTH·2017

Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome - characterization of the antibody.

Journal of thrombosis and haemostasis : JTH·2016

Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.

Journal of thrombosis and haemostasis : JTH·2016

A survey on the current clinical practices among obstetricians for the management of venous thromboembolism prevention in various hospitals in China.

Thrombosis research·2026

Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management.

Thrombosis research·2026

Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism.

Thrombosis research·2026

Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.

Thrombosis research·2026

Tranexamic acid and its use in early pregnancy; a scoping review.

Thrombosis research·2026

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Thrombosis research·2026

Knowledge on the Haemophilia Care Among Healthcare Providers in Tanzania: A Multicenter Cross-Sectional Study.

Journal of blood medicine·2026

Rapid spontaneous regression of a massive post-thrombolysis intracerebral hemorrhage: A case report.

Surgical neurology international·2026

Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein-Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection.

Frontiers in immunology·2026

Persistent Gingival Bleeding After Scaling: A Diagnostic Clue to von Willebrand Disease.

Clinical case reports·2026

Development and Validation of a Checklist for Safe Blood Transfusion in Anesthesia: A Methodological Study.

Health science reports·2026

Efficacy and safety comparison of hetrombopag and eltrombopag in children with cancer therapy-induced thrombocytopenia: a single-center retrospective study.

Frontiers in medicine·2026

Related Experiment Videos

Thrombomodulin inhibits the activation of factor XIII by thrombin

Related Concept Videos

Driving safety improves after individualized training: An RCT involving older drivers in an urban area.

Auto- and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.

Minimal factor XIII activity level to prevent major spontaneous bleeds.

Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies.

Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome - characterization of the antibody.

Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.

A survey on the current clinical practices among obstetricians for the management of venous thromboembolism prevention in various hospitals in China.

Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management.

Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism.

Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.

Tranexamic acid and its use in early pregnancy; a scoping review.

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Knowledge on the Haemophilia Care Among Healthcare Providers in Tanzania: A Multicenter Cross-Sectional Study.

Rapid spontaneous regression of a massive post-thrombolysis intracerebral hemorrhage: A case report.

Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein-Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection.

Persistent Gingival Bleeding After Scaling: A Diagnostic Clue to von Willebrand Disease.

Development and Validation of a Checklist for Safe Blood Transfusion in Anesthesia: A Methodological Study.

Efficacy and safety comparison of hetrombopag and eltrombopag in children with cancer therapy-induced thrombocytopenia: a single-center retrospective study.

Related Experiment Videos

Thrombomodulin inhibits the activation of factor XIII by thrombin

Related Concept Videos

Related Articles